Schering-Plough, Chr. Hansen Holding A/S deal

SGP and CHRH's Alk-Abello subsidiary partnered to run a Phase IIb/III Prograss trial of Alk-Abello's oral tablet to treat grass pollen allergy. The double-blind, placebo-controlled trial is expected t...